BTC$66,305.00+1.58%
ETH$1,920.55+0.88%
USDT$0.9993+0.01%
BNB$572.45+0.09%
USDC$0.9999+0.00%
XRP$1.15+2.86%
SOL$77.80-0.04%
TRX$0.3295+0.94%
FIGR_HELOC$1.01+0.43%
HYPE$60.43-3.66%
DOGE$0.0735+1.83%
RAIN$0.0148+4.28%
USDS$0.9998+0.00%
LEO$9.71-0.14%
ZEC$529.73-3.33%
WBT$57.70+1.35%
BTC$66,305.00+1.58%
ETH$1,920.55+0.88%
USDT$0.9993+0.01%
BNB$572.45+0.09%
USDC$0.9999+0.00%
XRP$1.15+2.86%
SOL$77.80-0.04%
TRX$0.3295+0.94%
FIGR_HELOC$1.01+0.43%
HYPE$60.43-3.66%
DOGE$0.0735+1.83%
RAIN$0.0148+4.28%
USDS$0.9998+0.00%
LEO$9.71-0.14%
ZEC$529.73-3.33%
WBT$57.70+1.35%
Thermo Fisher Scientific beat Q4 expectations with EPS of $6.57 on revenue of $12.21 billion and shared its outlook for 2026.
Thermo Fisher Scientific reported 5% revenue growth in Q3 2025 with adjusted EPS of $5.79, beating expectations and reinforcing its positive long-term outlook.
Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.
Thermo Fisher Scientific Inc. (NYSE: TMO) reported a revenue of $10.60 billion in the third quarter of 2024.
Thermo Fisher Scientific reported $10.54 billion in revenue for Q2 2024.
Thermo Fisher Scientific Inc. has showcased its financial strength in the first quarter of 2024, with a slight revenue decline but commendable growth in GAAP diluted…
Thermo Fisher Scientific Inc. (NYSE: TMO) has reported a strong fourth quarter for 2023, surpassing financial expectations with a slight increase in EPS and higher-than-expected revenue.